Dupilumab to Treat Type 2 Inflammatory Diseases in Children and Adolescents
Amelia Licari, Riccardo Castagnoli, Alessia Marseglia, Francesca Olivero, Martina Votto, Giorgio Ciprandi, Gian Luigi Marseglia
Topics & Concepts
DupilumabMedicineImmunologyAtopic dermatitisEosinophilic esophagitisContext (archaeology)Interleukin 13AsthmaImmunoglobulin ENasal polypsMepolizumabOmalizumabInterleukinDermatologyDiseaseEosinophilAntibodyCytokineInternal medicineBiologyPaleontologyAsthma and respiratory diseasesEosinophilic EsophagitisIL-33, ST2, and ILC Pathways